London · Delayed Price · Currency is GBP · Price in DKK Embla Medical Company Description
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care.
The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints.
Its Bracing and Supports segment provides bracing and supports products, such as supporting devices for spinal, hip, knee, foot, ankle, and hands; and injury solutions for people recovering from fractures, need post-operative treatment, and ligament injuries.
The Patient Care segment offers prosthetics for people with lower and upper limb loss or limb difference; and orthotics for neurological, gait, and musculoskeletal conditions.
It serves specialized healthcare providers, such as orthopedic and prosthetic clinics, hospitals, and surgery centers.
It sells its products through its direct sales networks and distributors. The company was formerly known as Össur hf. and changed its name to Embla Medical hf. in April 2024.
Embla Medical hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Embla Medical hf. is a subsidiary of William Demant Invest A/S.
| Country | Iceland |
| Founded | 1971 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| Employees | 4,061 |
| CEO | Sveinn Solvason |
Contact Details
Address: Grjótháls 5 Reykjavik Iceland | |
| Website | emblamedical.com |
Stock Details
| Ticker Symbol | 0FIW |
| Exchange | London Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Sveinn Solvason | Chief Executive Officer |
| Gudny Sveinsdottir | Chief Financial Officer |
| Lukas Marklin | Chief Operating Officer |
| Klaus Sindahl | Head of Investor Relations |